Proteus launches its first digital cancer chemotherapy pill


Former Fierce 15 winner Proteus Digital Health has launched an oral chemotherapy equipped with an ingestible sensor, helping oncologists track treatment effectiveness and patient adherence.


The smart pill is first being offered as part of a collaboration between Proteus, the University of Minnesota health system, and Fairview Health Services. They will be prescribing digital capecitabine to treat patients with stages 3 and 4 colorectal cancer. The pill’s embedded sensor activates in stomach acid and sends an electronic signal before dissolving.


Read the full article at…


Comments are closed.

Read previous post:
DNA Company 23andMe Gets FDA Approval for Consumer Cancer Test

DNA testing company 23andMe has gotten approval from the FDA for a consumer test detecting hereditary colorectal cancer syndrome by...